Jinling Pharmaceutical: Prompt Announcement of Jinling Pharmaceutical Co., Ltd. on the holding of the 3rd Extraordinary General Meeting of Shareholders in 2024
Jinling Pharmaceutical: Announcement of the progress of Jinling Pharmaceutical Co., Ltd. on the use of idle funds raised for cash management
Jinling Pharmaceutical: Announcement of the progress of Jinling Pharmaceutical Co., Ltd. on the use of idle funds raised for cash management
Jinling Pharmaceutical: 2024 Semi-Annual Report Summary
Jinling Pharmaceutical: Audit opinion of the board of supervisors of Jinling Pharmaceutical Co., Ltd. on matters related to the 12th meeting of the 9th Board of Supervisors
Jinling Pharmaceutical: Articles of Association of Jinling Pharmaceutical Co., Ltd. (August 2024)
Jinling Pharmaceutical: Verification Report on Jinling Pharmaceutical Co., Ltd.\'s use of raised funds to replace self-raised funds that have already paid issuance fees
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the use of raised funds to replace self-raised funds that have already paid distribution fees
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the progress of the company and its subsidiaries using idle own funds to purchase wealth management products
Jinling Pharmaceutical: Verification Opinions of CITIC Securities Co., Ltd. on Jinling Pharmaceutical Co., Ltd.\'s use of raised funds to replace self-funded funds already paid for issuance
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on adjusting the repurchase price of the 2021 Restricted Stock Incentive Plan and the repurchase and cancellation of some restricted stocks that have been granted but the sales restrictions have not yet been lifted
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on changing the registered capital and amending the “Articles of Association”
Jinling Pharmaceutical: Semi-Annual Report Board Resolution Announcement
Jinling Pharmaceutical: Semi-Annual Report 2024
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on Jinling Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan Repurchase Price Adjustment and Repurchase Cancellation of Some Restricted Shares
Jinling Pharmaceutical: 2024 Semi-Annual Financial Report
Jinling Pharmaceutical: Semi-annual non-operating capital usage and other related capital transactions summary table
Jinling Pharmaceutical: Announcement of the resolution of the semi-annual report of the Supervisory Committee
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on adjusting the positions of the company\'s senior management personnel and appointing an assistant to the company\'s president
Jinling Pharmaceutical: Special Report of Jinling Pharmaceutical Co., Ltd. on the storage and use of funds raised for the first half year of 2024
No Data